Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Curaleaf Holdings Inc T.CURA

Alternate Symbol(s):  CURLF

Curaleaf Holdings, Inc. is an international provider of consumer cannabis products. The Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide selection and accessibility across the medical and adult use markets. It operates in approximately 17 states and owns and operates 147 dispensaries and 21 cultivation sites with a focus on states, including... see more

TSX:CURA - Post Discussion

Curaleaf Holdings Inc > Big Pharma Will Continue to Fight Pot Legalization
View:
Post by ledzep4u on Apr 19, 2023 3:48pm

Big Pharma Will Continue to Fight Pot Legalization

Ever wonder why SAFE didn't passed last year-end? 

Wonder why Biden was pro legalization before the last election and then nothing?

Wonder why legalization has and will face a battle at the federal level? 

Well, it's all about big pharma and how they have been the biggest lobby spenders annually for over 20 years? Money always talks and gets its way. 

https://www.statista.com/statistics/257364/top-lobbying-industries-in-the-us/
Comment by Bullknit101 on Apr 19, 2023 9:15pm
Curaleaf will have clout.  Company expects its revenue for the fourth quarter of 2022 to be approximately US $352 million
Comment by Bullknit101 on Apr 19, 2023 10:11pm
The irony is that Cannabis should be part of Big Pharma. The ignorance out there is staggering. There are 500 chemical compounds in the Cannabis plant, many with great and undiscoverd pharmaceutical benefits. (CBN, CBC, THCV, CBD, CBG, CBT and the list goes on)  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities